tiprankstipranks
Jubilant Pharmova Limited (IN:JUBLPHARMA)
:JUBLPHARMA
India Market
Want to see IN:JUBLPHARMA full AI Analyst Report?

Jubilant Pharmova Limited (JUBLPHARMA) Financial Statements

2 Followers

Jubilant Pharmova Limited Financial Overview

Jubilant Pharmova Limited's market cap is currently ₹160.20B. The company's EPS TTM is ₹30.16; its P/E ratio is 32.46; and it has a dividend yield of 0.46%. Jubilant Pharmova Limited is scheduled to report earnings on May 22, 2026, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 25Mar 24Mar 23Mar 22
Income Statement
Total Revenue₹ 82.80B₹ 72.34B₹ 67.03B₹ 62.82B₹ 61.30B
Gross Profit₹ 24.94B₹ 46.99B₹ 43.52B₹ 42.00B₹ 46.42B
Operating Income₹ 8.19B₹ 23.56B₹ 20.64B₹ 19.85B₹ 25.68B
EBITDA₹ 12.60B₹ 10.48B₹ 7.93B₹ 6.46B₹ 10.66B
Net Income₹ 3.98B₹ 8.39B₹ 771.00M₹ -610.00M₹ 4.14B
Balance Sheet
Cash & Short-Term Investments₹ 12.68B₹ 10.89B₹ 9.56B₹ 10.15B₹ 9.86B
Total Assets₹ 155.23B₹ 127.56B₹ 115.48B₹ 111.57B₹ 99.91B
Total Debt₹ 36.15B₹ 27.31B₹ 36.64B₹ 36.77B₹ 31.92B
Net Debt₹ 23.47B₹ 16.42B₹ 27.10B₹ 26.63B₹ 22.12B
Total Liabilities₹ 84.27B₹ 65.18B₹ 61.27B₹ 57.65B₹ 46.74B
Stockholders' Equity₹ 70.93B₹ 62.55B₹ 54.34B₹ 53.99B₹ 53.19B
Cash Flow
Free Cash Flow₹ -4.36B₹ -435.00M₹ 736.00M₹ -1.54B₹ 2.38B
Operating Cash Flow₹ 10.13B₹ 10.72B₹ 9.71B₹ 6.61B₹ 8.38B
Investing Cash Flow₹ -12.85B₹ 4.88B₹ -6.08B₹ -5.44B₹ -3.80B
Financing Cash Flow₹ 3.33B₹ -14.53B₹ -4.33B₹ -1.57B₹ -325.99M
Currency in INR

Jubilant Pharmova Limited Earnings and Revenue History

Jubilant Pharmova Limited Debt to Assets

Jubilant Pharmova Limited Cash Flow

Jubilant Pharmova Limited Forecast EPS vs Actual EPS